InsiderDirector

Vicki L Sato Insider Trading Activity

Every SEC Form 4 transaction reported by Vicki L Sato, sourced directly from SEC EDGAR and updated as new filings are accepted.

By · Insider-trading data from SEC EDGAR
Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Vicki L Sato buying or selling?

Vicki L Sato reported 0 open-market buys ($0) and 64 sells ($15.8M) across 64 Form 4 filings at 2 companies — a net selling position of $15.8M.

Source: SEC EDGAR Form 4

What stands out

  • Vicki L Sato has reported Form 4 transactions at 2 companies; the most active, Vir Biotechnology, Inc. (VIR), accounts for 36 of 64 filings (56%).
  • The most recent Form 4 was accepted on May 4, 2026 (5 months ago).
  • In the last 12 months: no open-market purchases and 8 sales ($1.6M).
  • The largest open-market sale in the last 12 months was $413.4K of Vir Biotechnology, Inc. (VIR) on Feb 26, 2026. SEC ↗

Key Statistics (as of May 4, 2026)

Total Form 4 filings
64
SEC EDGAR
Companies
2
Buys (0)
$0
Sells (64)
$15.8M

Insider sentiment

Net selling

Net insider flow of $15.8M in net selling, filed between Mar 4, 2021 – May 4, 2026.

Companies Vicki L Sato files for

#CompanyForm 4 filings
1VIRVir Biotechnology, Inc.36
2DNLIDenali Therapeutics Inc.28

Recent Vicki L Sato transactions

DateTickerRoleTypeSharesValueFiling
May 4, 2026VIRDirectorSale22.0K$221.0KSEC ↗
Apr 2, 2026VIRDirectorSale22.0K$199.6KSEC ↗
Mar 3, 2026VIRDirectorSale22.0K$209.2KSEC ↗
Feb 26, 2026VIRDirectorSale42.4K$413.4KSEC ↗
Feb 3, 2026VIRDirectorSale22.0K$169.7KSEC ↗
Jan 5, 2026VIRDirectorSale22.0K$130.4KSEC ↗
Dec 3, 2025VIRDirectorSale22.0K$132.1KSEC ↗
Nov 4, 2025VIRDirectorSale22.0K$124.0KSEC ↗
Oct 2, 2025VIRDirectorSale22.0K$128.4KSEC ↗
Sep 3, 2025VIRDirectorSale22.0K$109.8KSEC ↗
Aug 4, 2025VIRDirectorSale22.0K$109.7KSEC ↗
Jul 2, 2025VIRDirectorSale22.0K$112.2KSEC ↗
Jan 9, 2025VIRDirectorSale11.0K$137.2KSEC ↗
Jan 3, 2025DNLIDirectorSale3.1K$64.4KSEC ↗
Nov 12, 2024DNLIDirectorSale1.0K$30.6KSEC ↗
Nov 5, 2024DNLIDirectorSale3.1K$83.4KSEC ↗
Sep 16, 2024DNLIDirectorSale1.0K$30.6KSEC ↗
Sep 4, 2024DNLIDirectorSale3.1K$77.0KSEC ↗
Jul 4, 2024DNLIDirectorSale3.1K$68.2KSEC ↗
May 17, 2024DNLIDirectorSale1.7K$34.1KSEC ↗
Apr 17, 2024DNLIDirectorSale1.7K$30.5KSEC ↗
Mar 19, 2024DNLIDirectorSale1.7K$33.5KSEC ↗
Feb 20, 2024DNLIDirectorSale1.7K$30.6KSEC ↗
Jan 18, 2024DNLIDirectorSale1.7K$30.7KSEC ↗
Dec 19, 2023DNLIDirectorSale1.7K$39.0KSEC ↗

Showing the 25 most recent filings of 64. Screen every filing.

Vicki L Sato insider trading FAQ

Is Vicki L Sato buying or selling?

Across 64 SEC Form 4 filings, Vicki L Sato reported 0 open-market purchases totaling $0 and 64 sales totaling $15.8M — a net selling position of $15.8M.

Which companies does Vicki L Sato file Form 4s for?

Vicki L Sato has reported insider transactions at 2 companies, most often Vir Biotechnology, Inc. (VIR), Denali Therapeutics Inc. (DNLI).

How far back does Vicki L Sato's filing history go?

Trabud holds Vicki L Sato's SEC Form 4 filings from Mar 4, 2021 – May 4, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Vicki L Sato's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Learn

What is SEC Form 4?

The filing behind every transaction here

Guide

How to Track Insider Trading

A practical workflow for following Form 4 activity

Use Case

Insider Buying Signals

How investors read insider purchases

Track Vicki L Sato and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener